1,636 results on '"Strom, A. B."'
Search Results
202. Abstract 301: Differential Outcomes for Geriatric Patients in Cardiac Intensive Care Unit Compared to Medical Intensive Care Unit
203. Abstract 20: Use of Administrative Claims to Ascertain Outcomes in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the Extending Trial-based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study
204. Saving Islets from Allograft Rejection
205. THE IDENTIFICATION OF NEED FOR ULTRASOUND ENHANCING AGENT STUDY (THE IN-USE STUDY)
206. ASSESSING FRAILTY-ASSOCIATED CHARACTERISTICS AND OUTCOMES IN THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY USING MEDICARE CLAIMS: INSIGHTS FROM THE EXTEND-DAPT STUDY
207. ECHOCARDIOGRAPHIC AND CLINICAL VARIABLES ARE DIFFERENTIALLY PREDICTIVE OF HEART FAILURE HOSPITALIZATION IN HEART FAILURE WITH PRESERVED VERSUS REDUCED EJECTION FRACTION
208. MITRAL REGURGITATION AND IMPACT ON OUTCOMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A TOPCAT ANALYSIS
209. CHARACTERISTICS AND SIGNIFICANCE OF TRICUSPID VALVE PROLAPSE IN A LARGE MULTIDECADE ECHOCARDIOGRAPHIC STUDY
210. Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
211. T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation
212. Donor-strain-derived immature dendritic cell pre-treatment induced hyporesponsiveness against allogeneic antigens
213. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
214. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
215. Abstracts of the 6th FECS Conference 1998 Lectures
216. Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations
217. Poster Board #-Session: P254-II Isolated CD39 Expression on CD4+ T Cells Denotes Both Regulatory and Memory Populations.: Abstract# 1234
218. Total structure characterization of unsaturated acidic phospholipids provided by vicinal di-hydroxylation of fatty acid double bonds and negative electrospray ionization mass spectrometry
219. Immunoregulatory drugs: mechanistic basis for use in organ transplantation
220. Interleukin-2 Fusion Protein (DAB389IL- 2) Selectively Targets Activated Human Peripheral Blood and Lamina Propria Lymphocytes
221. In primed allo-tolerance, TIM-3-Ig rapidly suppresses TGFβ, but has no immediate effect on Foxp3
222. Cytokines in the Treatment and Prevention of Autoimmune Responses—A Role of IL-15
223. Antibodies, fusion proteins, and peptides: 402.4
224. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
225. Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen-Specific Regulatory T Cells
226. Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation
227. Depletion of CD8 Memory T Cells for Induction of Tolerance of a Previously Transplanted Kidney Allograft
228. Immunobiology and immunopharmacology of organ allograft rejection
229. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance
230. Mast cells are essential intermediaries in regulatory T-cell tolerance
231. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
232. Out-of-pocket costs of HAART limit HIV treatment responses in Botswanaʼs private sector
233. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
234. Prolonged Survival of Allogeneic Islets in Cynomolgus Monkeys After Short-Term Anti-CD154-Based Therapy: Nonimmunologic Graft Failure?
235. Transcriptional profiling to assess the clinical status of kidney transplants
236. Rejection - More Than the Eye Can See
237. On the Intraoperative Molecular Status of Renal Allografts after Vascular Reperfusion and Clinical Outcomes
238. Immunological tolerance and liver transplantation
239. Insulin-Induced Augmentation of Lymphocyte-Mediated Cytotoxicity
240. Selective Elimination of HIV-1-Infected Cells with an Interleukin-2 Receptor-Specific Cytotoxin
241. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease
242. Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger
243. Is transplantation tolerable?
244. Allogeneic Stem Cell-Derived “Repair Unit” Therapy and the Barriers to Clinical Deployment
245. Routes to Transplant Tolerance versus Rejection: The Role of Cytokines
246. Use of a reperfusion catheter after angioplasty dissection for salvage of ischemic renal allograft: Case report
247. The balance of deletion and regulation in allograft tolerance
248. Favorably Tipping the Balance between Cytopathic and Regulatory T Cells to Create Transplantation Tolerance
249. A refined understanding of immunosuppressives and cancer risk
250. Renal transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.